在白血病中介质干细胞的生物学和治疗特性
Cheng-Hsien Wu1, Te-Fu Weng2,3, Ju-Pi Li2,4
1School of Medicine, National Defense Medical Center, Taipei 114, Taiwan.
International journal of molecular sciences
|March 13, 2024
概括
介酶干细胞 (MSC) 在白血病中起着复杂的作用,影响疾病的进展和治疗. 了解它们在骨髓微环境中的双重功能是开发血液癌症新疗法的关键.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
背景情况:
- 介质干细胞 (MSC) 是骨髓 (BM) 微环境的关键组成部分.
- 多细胞干细胞会影响造血干细胞功能和免疫调节.
- 它们与白血病细胞的相互作用会影响白血病的发展和进展.
研究的目的:
- 综合审查MSC在各种类型的白血病中的多方面的作用.
- 探索MSCs在BM微环境中的相互作用及其对白血病发病,进展和治疗耐药性的影响.
- 讨论MSCs在白血病治疗和克服化疗耐药性的潜在临床应用.
主要方法:
- 对MSC和白血病现有研究的文献综述.
- 在急性髓性白血病,急性淋巴细胞白血病,慢性髓性白血病和慢性淋巴细胞白血病中分析MSC与白血病细胞的相互作用.
- 检查MSC在造血干细胞移植中的作用及其抗瘤作用.
主要成果:
- MSCs具有双重作用,可能促进或抑制白血病的生长.
- MSCs影响白血病的进展,并导致治疗耐药性.
- 了解MSC的机制对于治疗策略至关重要.
结论:
- MSC对血液性恶性瘤有着重大影响,为治疗提供了机遇和挑战.
- 准MSC为新型白血病治疗策略提供了潜力.
- 需要进一步的研究,以充分阐明MSC机制,并优化其临床应用.
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
329
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
329
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K


